header_analytical
Analytical Services at BioSpring

Release Testing
& Stability Studies

Nucleic Acid Analysis

Release Testing & Stability Studies

Bringing a nucleic acid-based therapy to market requires precise, compliant, and reliable analytical data. At BioSpring, we provide comprehensive in-house release testing and ICH-compliant stability studies to ensure the quality, safety, and consistency of your API and drug product—from early development through commercialization.

What you gain with BioSpring’s release & stability testing:

IconsShape_114

Confidence in Every Batch

Our precise release testing ensures your product meets all quality specifications before it reaches patients

IconsShape_114

Regulatory Compliance Made Easy

FDA-inspected, cGMP-certified, and fully aligned with global regulatory requirements

IconsShape_114

Customized Testing for Your Needs

Flexible and tailored release & stability study scopes, supporting products at all stages of development

IconsShape_114

Long-Term Product Integrity

ICH-compliant stability programs assess degradation profiles and shelf-life under real-world conditions

IconsShape_114

Proven Industry Expertise

Supporting eight commercial oligonucleotide products with industry-leading analytical solutions

With BioSpring, you gain a trusted partner who ensures your nucleic acid-based therapy meets the highest quality and regulatory standards—every step of the way.

Learn more about our solutions

Explore More

Discover our comprehensive analytical services to support your nucleic acid programs at every stage: 

Bioanalytical Services, Characterization, 
Method Development & Transfer, Method Validation, & more